| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |